Navigation Links
Evonik and Genedata Broaden Their Collaboration with the Genedata Selector Biotechnology Data Management Platform
Date:9/17/2013

Basel, Switzerland (PRWEB) September 17, 2013

Genedata, a leading provider of advanced software solutions for industrial, agricultural, drug discovery, and life science research, today announced that Evonik is extending its collaboration with Genedata. Building on its long-standing partnership with Genedata, Evonik is using the Genedata fully integrated offering that includes Genedata Selector™ for the management and analysis of strain information, scientific data analysis consulting provided by Genedata bioinformatics experts, and specialized IT services. The integrated solution from Genedata will help Evonik advance its industry diversification projects and strengthen the return on its strategic biotechnology investments.

“New, data-intensive and omics-based technologies are catalysts for innovation in the health and food industries,” noted Dr. Ralf Kelle, vice president of R&D Bioproducts for the Evonik Health and Nutrition business unit. “Genedata – with its domain expertise in data analysis and management – helps us get maximum value from our data. More importantly, our relationship with Genedata allows us to benefit from their innovative solutions, which contribute to the success of our resource-efficient and sustainable biotechnology research.”

Beyond Software – Scientific Data Analysis Consulting & Specialized IT Services
Evonik has successfully used Genedata Selector to manage, visualize, and analyze complete genomes of production strain collections with a focus on mutation analysis and deciphering complex genotype-phenotype relationships. Genedata Selector accelerates difficult strain optimization projects for the production of bio-based chemicals, nutritional proteins, food and feed additives, and cosmetics ingredients.

Now, in addition to Genedata Selector enterprise software, Evonik will also use Genedata scientific data analysis consulting services. Based on in-depth and extensive experience in the industrial biotechnology field, these value-added services help to eliminate resource bottlenecks, provide cost-effective support for strategically important projects, and deliver valuable results quickly and efficiently.

Addressing the complete life cycle of R&D projects – from early-stage feasibility studies to late-stage product development – Genedata scientific data analysis consulting delivers:

  • proprietary genome annotations, including gene calling and functional annotations up to the pathway level (for prokaryotes as well as eukaryotes);
  • production strain comparisons, including interpretations of biological effects of variants (e.g. on enzyme activities);
  • cellular signaling network reconstructions for proprietary strains, based on expression and regulatory sequence data;
  • biomarkers, based on omics, NGS, pathway, and functional annotation data; and
  • statistical expression analysis reports (e.g. of microarray or RNAseq data).

In the enterprise R&D environment, Genedata specialized IT services ensure server availability and infrastructure stability for high-performance server infrastructures. These services, which empower researchers to focus more on scientific discovery, include:

  • hosting and remote server maintenance;
  • software and database integration services; and
  • data migration and integration services, including public domain genome release monitoring.

“We are proud of our long-standing and successful partnership with Evonik, a world leader in specialty chemicals,” noted Dr. Othmar Pfannes, CEO of Genedata. “Their adoption of the Genedata Selector application suite, coupled with our scientific consulting and professional IT services, serves as an industry model for other customers in industrial biotechnology research who want to leverage the full advantage of our bioinformatics expertise to achieve their business objectives.”

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com

Read the full story at http://www.prweb.com/releases/2013/9/prweb11088626.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening
2. Genedata Screener Extends Support for High-Throughput Thermofluor Assays
3. Genedata at ESACT Announces Expansion Into Biopharma Process Development
4. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
5. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
6. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
7. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
8. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
9. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
10. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
11. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... ... NDA Partners Chairman Carl Peck, MD , announced today that John W. ... Center for Devices and Radiological Health and recognized leader in the medical device, pharmaceutical ... his FDA experience, Dr. Sheets served in senior technical leadership roles in a series ...
(Date:8/21/2017)... USA (PRWEB) , ... August 20, 2017 , ... ... the Journal of Biomedical Optics (JBO) starting 1 January 2018. The journal is ... of Biomedical Optics publishes papers on the use of modern optical technology for ...
(Date:8/21/2017)... ... August 21, 2017 , ... The team at ... educational webinar, in which attendees will learn about the assembly and topological architecture ... with an overview of the development and validation of new high-quality recombinant monoclonal ...
(Date:8/17/2017)... Westlake Village, CA (PRWEB) , ... August 17, ... ... biopsy technology for cancer research and personalized medicine, today announced the launch of ... in Kansas City, Missouri. The study’s goal is to evaluate the potential for ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):